Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
4D Molecular Therapeutics, Inc. (FDMT) had Current Liabilities of $47.67M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$3.78M |
|
$-72.94M |
|
-- |
|
$3.78M |
|
$80.81M |
|
$-77.03M |
|
$4.09M |
|
$-72.94M |
|
$-72.94M |
|
$-72.94M |
|
$-72.94M |
|
$-72.94M |
|
$-72.94M |
|
$-77.03M |
|
$-76.73M |
|
70.27M |
|
70.27M |
|
$-1.04 |
|
$-1.04 |
|
| Balance Sheet Financials | |
$382.96M |
|
$12.38M |
|
$109.66M |
|
$492.62M |
|
|
Current Liabilities |
$47.67M |
$19.59M |
|
$37.28M |
|
$84.96M |
|
$407.66M |
|
$407.66M |
|
$407.66M |
|
55.21M |
|
| Cash Flow Statement Financials | |
$-138.12M |
|
$94.43M |
|
$53.82M |
|
$60.24M |
|
$70.37M |
|
$10.13M |
|
$10.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.03 |
|
-- |
|
-- |
|
0.05 |
|
0.05 |
|
100.00% |
|
-2037.16% |
|
-2037.16% |
|
-- |
|
-1929.01% |
|
-1929.01% |
|
$-138.18M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.82 |
|
109.76 |
|
-17.89% |
|
-17.89% |
|
-14.81% |
|
-17.07% |
|
$7.38 |
|
$-1.97 |
|
$-1.97 |
|